Ipek Özer Stillman

947 total citations · 1 hit paper
14 papers, 672 citations indexed

About

Ipek Özer Stillman is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Ipek Özer Stillman has authored 14 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in General Health Professions. Recurrent topics in Ipek Özer Stillman's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Ocular Surface and Contact Lens (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Ipek Özer Stillman is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Ocular Surface and Contact Lens (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Ipek Özer Stillman collaborates with scholars based in United States, Japan and Canada. Ipek Özer Stillman's co-authors include Debra A. Schaumberg, Kimberly F Farrand, Moshe Fridman, Reza Dana, Irina Pivneva, Annie Guérin, Amber Evans, John L. Bradley, Denis Getsios and P McEwan and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Ophthalmology and Frontiers in Pharmacology.

In The Last Decade

Ipek Özer Stillman

12 papers receiving 650 citations

Hit Papers

Prevalence of Diagnosed Dry Eye Disease in the United Sta... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older
    2017 386 citations Kimberly F Farrand, Moshe Fridman et al. American Journal of Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ipek Özer Stillman United States 7 575 243 228 167 157 14 672
Sueko M Ng United States 14 437 0.8× 81 0.3× 394 1.7× 512 3.1× 79 0.5× 27 832
Melissa Toyos United States 12 402 0.7× 121 0.5× 279 1.2× 194 1.2× 144 0.9× 22 559
Rose M. Sullivan United States 6 545 0.9× 171 0.7× 208 0.9× 112 0.7× 181 1.2× 7 613
Jason Bacharach United States 14 350 0.6× 106 0.4× 723 3.2× 416 2.5× 101 0.6× 39 962
David Wirta United States 17 426 0.7× 109 0.4× 366 1.6× 213 1.3× 146 0.9× 44 762
Kenta Fujio Japan 15 431 0.7× 200 0.8× 256 1.1× 171 1.0× 129 0.8× 37 623
Dorothy Tolls United States 8 339 0.6× 65 0.3× 338 1.5× 252 1.5× 101 0.6× 13 573
Samantha K. Ward Japan 8 408 0.7× 83 0.3× 212 0.9× 171 1.0× 80 0.5× 9 477
Stefano Sebastiani Italy 13 416 0.7× 61 0.3× 365 1.6× 344 2.1× 84 0.5× 22 635
Kyle Huynh United States 7 256 0.4× 102 0.4× 116 0.5× 88 0.5× 65 0.4× 9 358

Countries citing papers authored by Ipek Özer Stillman

Since Specialization
Citations

This map shows the geographic impact of Ipek Özer Stillman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ipek Özer Stillman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ipek Özer Stillman more than expected).

Fields of papers citing papers by Ipek Özer Stillman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ipek Özer Stillman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ipek Özer Stillman. The network helps show where Ipek Özer Stillman may publish in the future.

Co-authorship network of co-authors of Ipek Özer Stillman

This figure shows the co-authorship network connecting the top 25 collaborators of Ipek Özer Stillman. A scholar is included among the top collaborators of Ipek Özer Stillman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ipek Özer Stillman. Ipek Özer Stillman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Stillman, Ipek Özer, et al.. (2025). Rooting patient-reported outcomes in clinical care: a scoping review on benefits, challenges, and opportunities for patients and clinicians. Health and Quality of Life Outcomes. 23(1). 93–93.
2.
Muir, Jeffrey M., Amruta Radhakrishnan, Ipek Özer Stillman, & Grammati Sarri. (2024). Health Equity Considerations in Cost-Effectiveness Analysis: Insights from an Umbrella Review. ClinicoEconomics and Outcomes Research. Volume 16. 581–596. 2 indexed citations
3.
Muir, Jeffrey M., Amruta Radhakrishnan, Andreas Freitag, Ipek Özer Stillman, & Grammati Sarri. (2023). Reconstructing the value puzzle in health technology assessment: a pragmatic review to determine which modelling methods can account for additional value elements. Frontiers in Pharmacology. 14. 1197259–1197259. 4 indexed citations
4.
Stillman, Ipek Özer, et al.. (2019). <p>Dry eye disease ranking among common reasons for seeking eye care in a large US claims database</p>. Clinical ophthalmology. Volume 13. 225–232. 46 indexed citations
5.
Dana, Reza, John L. Bradley, Annie Guérin, et al.. (2019). Estimated Prevalence and Incidence of Dry Eye Disease Based on Coding Analysis of a Large, All-age United States Health Care System. American Journal of Ophthalmology. 202. 47–54. 155 indexed citations
6.
Dana, Reza, John L. Bradley, Annie Guérin, et al.. (2018). Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study. American Journal of Ophthalmology. 198. 181–192. 23 indexed citations
7.
Farrand, Kimberly F, Moshe Fridman, Ipek Özer Stillman, & Debra A. Schaumberg. (2017). Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older. American Journal of Ophthalmology. 182. 90–98. 386 indexed citations breakdown →
8.
Stillman, Ipek Özer, et al.. (2015). Cost-effectiveness analysis of second-line tyrosine kinase inhibitor treatment for chronic myelogenous leukemia. Journal of Medical Economics. 19(5). 445–461. 12 indexed citations
9.
10.
Stillman, Ipek Özer, et al.. (2014). The relationship between overall survival (OS) and progression-free survival (PFS) in gastrointestinal stromal tumor (GIST).. Journal of Clinical Oncology. 32(15_suppl). 10557–10557.
11.
Stillman, Ipek Özer, et al.. (2014). P2‐320: COST‐EFFECTIVENESS OF MEMANTINE EXTENDED RELEASE FOR TREATMENT OF MODERATE‐TO‐SEVERE ALZHEIMER'S DISEASE IN THE UNITED STATES. Alzheimer s & Dementia. 10(4S_Part_15). 2 indexed citations
12.
13.
Su, Wayne, Gayatri Ranganathan, Mkaya Mwamburi, et al.. (2012). Cost-effectiveness analysis of bendamustine plus rituximab versus CHOP-R in treatment-naive patients with mantle cell (MCL) and indolent lymphomas (IL).. Journal of Clinical Oncology. 30(15_suppl). 6553–6553. 2 indexed citations
14.
Jaime, J., et al.. (2007). Cost effectiveness of rimonabant use in patients at increased cardiometabolic risk: estimates from a Markov model. Journal of Medical Economics. 10(3). 239–254. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sueko M Ng Breakdown of academic impact, for papers by Melissa Toyos Breakdown of academic impact, for papers by Rose M. Sullivan Breakdown of academic impact, for papers by Jason Bacharach Breakdown of academic impact, for papers by David Wirta Breakdown of academic impact, for papers by Kenta Fujio Breakdown of academic impact, for papers by Dorothy Tolls Breakdown of academic impact, for papers by Samantha K. Ward Breakdown of academic impact, for papers by Stefano Sebastiani Breakdown of academic impact, for papers by Kyle Huynh
Rankless by CCL
2026